Key Opinion Leader- Ultherapy
Dr Stephen Lowe is internationally recognised as a Key Opinion Leader (KOL) for Ultherapy, reflecting a level of clinical expertise and contribution that extends well beyond everyday practice.
In 2021, he was invited to join the Ultherapy Global Task Force—a highly selective group of physicians, surgeons, and scientists entrusted with guiding the future direction of Ultherapy. This group has played a central role in shaping treatment protocols, safety frameworks, and technological advancements, including the development of Ultherapy PRIME.
As part of this select international group, Dr Lowe is among a small number of clinicians globally involved in both the clinical application and ongoing evolution of micro-focused ultrasound technology.
Based in Sydney, he applies this expertise in clinical practice, offering Ultherapy treatments that are grounded in evidence, anatomy, and long-term skin health.
With formal training in both public health and aesthetic medicine (MPH, MSc Aesthetic Medicine), Dr Lowe approaches Ultherapy through a rigorous clinical lens. His work has contributed to a deeper understanding of how ultrasound energy interacts with the skin’s structural layers—supporting collagen stimulation, improving firmness, and enhancing skin integrity over time.
Dr Lowe is regularly invited to speak at international conferences and educational forums, and has contributed to a range of publications on Ultherapy, where he presents on techniques, clinical outcomes, and emerging research. These invitations reflect peer recognition of his expertise and his role in advancing best practice within the field. He has also discussed Ultherapy in external media, including podcast interviews on micro-focused ultrasound and treatment planning.
As an educator, he is actively involved in training doctors, nurses, and dermal clinicians across Australia and internationally. His teaching focuses on precision, patient selection, and treatment planning—ensuring outcomes are consistent, appropriate, and grounded in clinical reasoning rather than trend-driven approaches.
For patients, this translates into a more considered and individualised experience of Ultherapy. Treatment decisions are made within the context of overall facial harmony, skin quality, and long-term outcomes—rather than isolated or short-term change.
Ultherapy treatments are performed at Muse Clinic in Sydney, where Dr Stephen Lowe applies these globally recognised protocols in clinical practice.
Key Speaking Events
Sydney, Australia 20/04/2026
Safety Through VisualisationUltherapy PRIME Visualisation Toolkit Launch
Ultherapy Australia
Bangkok, Thailand 26/02/2026
Ultherapy PRIME Advisory Board MeetingAPAC Ultherapy Visionaries Group
Ultherapy APAC
New York, USA 15/05/2025
Global Launch of Ultherapy PRIME with Selma HayekGlobal Ultherapy Task Force
Ultherapy Global
Brisbane, Australia 31/03/2025
Ultherapy PRIME: Setting foundationsUltherapy PRIME Australia Launch
Ultherapy Australia
Sydney, Australia 26/02/2025
Optimising Safety Through VisualisationUltherapy PRIME Australia Launch
Ultherapy Australia
Seoul, South Korea 27/01/2025
Ultherapy PRIME Advisory Board MeetingAPAC Ultherapy Visionaries Group
Ultherapy APAC
Los Angeles, USA 3-4/05/2024
Ultherapy: Setting The DirectionGlobal Ultherapy Task Force
Ultherapy Global
Bangkok, Thailand 17/02/2023
Achieving optimal outcomes for skin quality improvement through See Plan TreatSeeing Matters Conference
Ultherapy APAC
Melbourne, Australia 25/02/2022
Can single treatment, single depth superficial 1.5mm MFU-V be used for rhytid improvement?Australasian Society of Cosmetic Dermatology
Ultherapy Australia
Global, Virtual 20/11/2021
Current thinking on biostimulation: MFU-V for accordian linesMerz Aesthetics Expert Summit
Ultherapy Global
Global, Virtual 11/07/2021
Can single treatment, single treatment, single depth superficial 1.5mm MFU-V be used for rhytid improvement?IMCAS Asia
Ultherapy APAC
Global, Virtual 15/05/2021
Poster: Can single treatment, single depth superficial 1.5mm MFU-V be used for rhytid improvement?ASLMS
Ultherapy Global
Global, Virtual 13/11/2020
Evaluation of superficial MFU-V for the improvement of periorbital, perioral vertical and accordion linesNon-Surgical Symposium
Ultherapy Australia
Sydney, Australia 20/10/2019
Ultherapy for brow rejuvenationThe Masters Series: JJ Tour of Aesthetics
Ultherapy Australia
Sydney, Australia 05/04/2019
Ultherapy as a foundation treatmentCosmetex
Ultherapy Australia
Sydney, Australia 14/03/2019
Ultherapy as a foundation treatmentCosmedicon
Ultherapy Australia
Media
Lifting The Myths Around Ultherapy
muse@museclinic.com.au
Get Directions